Thiamylal: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 2: Line 2:
| verifiedrevid = 470606310
| verifiedrevid = 470606310
| IUPAC_name = 5-allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1''H'',5''H'')-dione
| IUPAC_name = 5-allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1''H'',5''H'')-dione
| image = ThiamylalSVG.svg
| image = ThiamylalSVG.png
| width = 100
| width = 100


Line 75: Line 75:
[[Category:Thiobarbiturates]]
[[Category:Thiobarbiturates]]
[[Category:Drug]]
[[Category:Drug]]
}

Latest revision as of 20:32, 10 April 2015

Thiamylal
Clinical data
SynonymsThiamylal, Thioseconal, Surital
AHFS/Drugs.comInternational Drug Names
ATCvet code
Legal status
Legal status
Pharmacokinetic data
MetabolismHepatic
Elimination half-life14.3 h (cats)
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H18N2O2S
Molar mass254.35 g/mol
3D model (JSmol)
  (verify)


WikiDoc Resources for Thiamylal

Articles

Most recent articles on Thiamylal

Most cited articles on Thiamylal

Review articles on Thiamylal

Articles on Thiamylal in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Thiamylal

Images of Thiamylal

Photos of Thiamylal

Podcasts & MP3s on Thiamylal

Videos on Thiamylal

Evidence Based Medicine

Cochrane Collaboration on Thiamylal

Bandolier on Thiamylal

TRIP on Thiamylal

Clinical Trials

Ongoing Trials on Thiamylal at Clinical Trials.gov

Trial results on Thiamylal

Clinical Trials on Thiamylal at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Thiamylal

NICE Guidance on Thiamylal

NHS PRODIGY Guidance

FDA on Thiamylal

CDC on Thiamylal

Books

Books on Thiamylal

News

Thiamylal in the news

Be alerted to news on Thiamylal

News trends on Thiamylal

Commentary

Blogs on Thiamylal

Definitions

Definitions of Thiamylal

Patient Resources / Community

Patient resources on Thiamylal

Discussion groups on Thiamylal

Patient Handouts on Thiamylal

Directions to Hospitals Treating Thiamylal

Risk calculators and risk factors for Thiamylal

Healthcare Provider Resources

Symptoms of Thiamylal

Causes & Risk Factors for Thiamylal

Diagnostic studies for Thiamylal

Treatment of Thiamylal

Continuing Medical Education (CME)

CME Programs on Thiamylal

International

Thiamylal en Espanol

Thiamylal en Francais

Business

Thiamylal in the Marketplace

Patents on Thiamylal

Experimental / Informatics

List of terms related to Thiamylal

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Thiamylal (Surital) is a barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant, and hypnotic effects, and is used as a strong but short acting sedative. Thiamylal is still in current use, primarily for induction in surgical anaesthesia [1] or as an anticonvulsant to counteract side effects from other anaesthetics.[2] It is the thiobarbiturate analogue of secobarbital.


References

  1. Hsieh MY, Hung GY, Hsieh YL, Chang CY, Hwang B. Deep sedation with methohexital or thiamylal with midazolam for invasive procedures in children with acute lymphoblastic leukemia. Acta Paediatrica Taiwan. 2005 Sep-Oct;46(5):294-300.
  2. Tsai CJ, Wang HM, Lu IC, Tai CF, Wang LF, Soo LY, Lu DV. Seizure after local anesthesia for nasopharyngeal angiofibroma. Kaohsiung Journal of Medical Sciences. 2007 Feb;23(2):97-100.